Regulation of lipid storage and inflammation in the liver by CEACAM1

This review focuses on a special aspect of hepatic lipid storage and inflammation that occurs during nutritional excess in obesity. Mounting evidence supports that prolonged excess fatty acid (FA) uptake in the liver is strongly associated with hepatic lipid storage and inflammation and that the two...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical investigation 2024-12, Vol.54 (S2), p.e14338-n/a
Hauptverfasser: Najjar, Sonia M., Shively, John E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue S2
container_start_page e14338
container_title European journal of clinical investigation
container_volume 54
creator Najjar, Sonia M.
Shively, John E.
description This review focuses on a special aspect of hepatic lipid storage and inflammation that occurs during nutritional excess in obesity. Mounting evidence supports that prolonged excess fatty acid (FA) uptake in the liver is strongly associated with hepatic lipid storage and inflammation and that the two processes are closely linked by a homeostatic mechanism. There is also strong evidence that bacterial lipids may enter the gut by a common mechanism with lipid absorption and that there is a set point to determine when their uptake triggers an inflammatory response in the liver. In fact, the progression from high uptake of FAs in the liver resulting in Metabolic dysfunction‐associated steatotic liver disease (MASLD) to the development of the more serious Metabolic dysfunction‐associated steatohepatitis (MASH) depends on the degree of inflammation and its progression from an acute to a chronic state. Thus, MASLD/MASH implicates both excess fatty acids and progressive inflammation in the aetiology of liver disease. We start the discussion by introduction of CD36, a major player in FA and lipopolysaccharide (LPS) uptake in the duodenum, liver and adipose tissue. We will then introduce CEACAM1, a major player in the regulation of hepatic de novo lipogenesis and the inflammatory response in the liver, and its dual association with CD36 in enterocytes and hepatocytes. We conclude that CEACAM1 and CD36 together regulate lipid droplet formation and inflammation in the liver. CEACAM1 associates with fatty acid (FA) binding protein CD36 in hepatocytes, and in the presence of LPS, forms a complex with TLR4 that phosphorylates SYK generating an inflammatory response. At the same time, phosphorylation of the ITIMs on CEACAM1 by SRC leads to recruitment of tyrosine phosphatase SHP2 that dampens the inflammation by dephosphorylation of SYK. During excess FAs and inflammation, hepatocytes begin to store triglyceride (TG) as lipid droplets (LDs) rather that export TGs in VLDL and LDL.
doi_str_mv 10.1111/eci.14338
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11646288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3144438688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2858-247c390cf965e372cf0dbfce6f81575e532e8add28ba5c93dd0d3b7a4cce56833</originalsourceid><addsrcrecordid>eNp1kU1L3UAUhoei1Kvton9AAm7qIjrfmazKJV4_QCmUdj1MZk6uI0nmOpNY7r83Gita8GzO4jw8vIcXoW8En5BpTsH6E8IZU5_QgjApcsok3UELjAnPaVnQPbSf0h3GWBFGP6M9VsqCK0UX6OwXrMfWDD70WWiy1m-8y9IQollDZnqX-b5pTdfNhO-z4RYm6gFiVm-zarWsljfkC9ptTJvg68s-QH_OV7-ry_z658VVtbzOLVVC5ZQXlpXYNqUUwApqG-zqxoJsFBGFAMEoKOMcVbURtmTOYcfqwnBrQUjF2AH6MXs3Y92Bs9AP0bR6E31n4lYH4_X7S-9v9To8aEIkl1SpyfD9xRDD_Qhp0J1PFtrW9BDGpBnhUnHFqZjQo__QuzDGfvrvieKcKfksPJ4pG0NKEZrXNATrp3L0VI5-LmdiD9_GfyX_tTEBpzPw17ew_dikV9XVrHwEKNGYBw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3144438688</pqid></control><display><type>article</type><title>Regulation of lipid storage and inflammation in the liver by CEACAM1</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Najjar, Sonia M. ; Shively, John E.</creator><creatorcontrib>Najjar, Sonia M. ; Shively, John E.</creatorcontrib><description>This review focuses on a special aspect of hepatic lipid storage and inflammation that occurs during nutritional excess in obesity. Mounting evidence supports that prolonged excess fatty acid (FA) uptake in the liver is strongly associated with hepatic lipid storage and inflammation and that the two processes are closely linked by a homeostatic mechanism. There is also strong evidence that bacterial lipids may enter the gut by a common mechanism with lipid absorption and that there is a set point to determine when their uptake triggers an inflammatory response in the liver. In fact, the progression from high uptake of FAs in the liver resulting in Metabolic dysfunction‐associated steatotic liver disease (MASLD) to the development of the more serious Metabolic dysfunction‐associated steatohepatitis (MASH) depends on the degree of inflammation and its progression from an acute to a chronic state. Thus, MASLD/MASH implicates both excess fatty acids and progressive inflammation in the aetiology of liver disease. We start the discussion by introduction of CD36, a major player in FA and lipopolysaccharide (LPS) uptake in the duodenum, liver and adipose tissue. We will then introduce CEACAM1, a major player in the regulation of hepatic de novo lipogenesis and the inflammatory response in the liver, and its dual association with CD36 in enterocytes and hepatocytes. We conclude that CEACAM1 and CD36 together regulate lipid droplet formation and inflammation in the liver. CEACAM1 associates with fatty acid (FA) binding protein CD36 in hepatocytes, and in the presence of LPS, forms a complex with TLR4 that phosphorylates SYK generating an inflammatory response. At the same time, phosphorylation of the ITIMs on CEACAM1 by SRC leads to recruitment of tyrosine phosphatase SHP2 that dampens the inflammation by dephosphorylation of SYK. During excess FAs and inflammation, hepatocytes begin to store triglyceride (TG) as lipid droplets (LDs) rather that export TGs in VLDL and LDL.</description><identifier>ISSN: 0014-2972</identifier><identifier>ISSN: 1365-2362</identifier><identifier>EISSN: 1365-2362</identifier><identifier>DOI: 10.1111/eci.14338</identifier><identifier>PMID: 39674882</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adipose tissue ; Animals ; Antigens, CD - metabolism ; CD36 ; CD36 antigen ; CD36 Antigens - metabolism ; CD66 antigen ; CEACAM1 ; CEACAM1 protein ; Cell Adhesion Molecules - metabolism ; Duodenum ; Enterocytes ; Fatty acids ; Fatty Acids - metabolism ; Fatty Liver - metabolism ; fatty liver disease ; Hepatocytes ; Hepatocytes - metabolism ; Humans ; Inflammation ; Inflammation - metabolism ; Inflammatory response ; Lipid metabolism ; Lipid Metabolism - physiology ; Lipids ; Lipogenesis ; Lipogenesis - physiology ; Lipopolysaccharides ; Liver ; Liver - metabolism ; Liver diseases ; LPS ; Metabolism ; Obesity - metabolism ; Review</subject><ispartof>European journal of clinical investigation, 2024-12, Vol.54 (S2), p.e14338-n/a</ispartof><rights>2024 The Author(s). published by John Wiley &amp; Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.</rights><rights>2024 The Author(s). European Journal of Clinical Investigation published by John Wiley &amp; Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2858-247c390cf965e372cf0dbfce6f81575e532e8add28ba5c93dd0d3b7a4cce56833</cites><orcidid>0000-0002-7763-770X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Feci.14338$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Feci.14338$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39674882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Najjar, Sonia M.</creatorcontrib><creatorcontrib>Shively, John E.</creatorcontrib><title>Regulation of lipid storage and inflammation in the liver by CEACAM1</title><title>European journal of clinical investigation</title><addtitle>Eur J Clin Invest</addtitle><description>This review focuses on a special aspect of hepatic lipid storage and inflammation that occurs during nutritional excess in obesity. Mounting evidence supports that prolonged excess fatty acid (FA) uptake in the liver is strongly associated with hepatic lipid storage and inflammation and that the two processes are closely linked by a homeostatic mechanism. There is also strong evidence that bacterial lipids may enter the gut by a common mechanism with lipid absorption and that there is a set point to determine when their uptake triggers an inflammatory response in the liver. In fact, the progression from high uptake of FAs in the liver resulting in Metabolic dysfunction‐associated steatotic liver disease (MASLD) to the development of the more serious Metabolic dysfunction‐associated steatohepatitis (MASH) depends on the degree of inflammation and its progression from an acute to a chronic state. Thus, MASLD/MASH implicates both excess fatty acids and progressive inflammation in the aetiology of liver disease. We start the discussion by introduction of CD36, a major player in FA and lipopolysaccharide (LPS) uptake in the duodenum, liver and adipose tissue. We will then introduce CEACAM1, a major player in the regulation of hepatic de novo lipogenesis and the inflammatory response in the liver, and its dual association with CD36 in enterocytes and hepatocytes. We conclude that CEACAM1 and CD36 together regulate lipid droplet formation and inflammation in the liver. CEACAM1 associates with fatty acid (FA) binding protein CD36 in hepatocytes, and in the presence of LPS, forms a complex with TLR4 that phosphorylates SYK generating an inflammatory response. At the same time, phosphorylation of the ITIMs on CEACAM1 by SRC leads to recruitment of tyrosine phosphatase SHP2 that dampens the inflammation by dephosphorylation of SYK. During excess FAs and inflammation, hepatocytes begin to store triglyceride (TG) as lipid droplets (LDs) rather that export TGs in VLDL and LDL.</description><subject>Adipose tissue</subject><subject>Animals</subject><subject>Antigens, CD - metabolism</subject><subject>CD36</subject><subject>CD36 antigen</subject><subject>CD36 Antigens - metabolism</subject><subject>CD66 antigen</subject><subject>CEACAM1</subject><subject>CEACAM1 protein</subject><subject>Cell Adhesion Molecules - metabolism</subject><subject>Duodenum</subject><subject>Enterocytes</subject><subject>Fatty acids</subject><subject>Fatty Acids - metabolism</subject><subject>Fatty Liver - metabolism</subject><subject>fatty liver disease</subject><subject>Hepatocytes</subject><subject>Hepatocytes - metabolism</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Inflammation - metabolism</subject><subject>Inflammatory response</subject><subject>Lipid metabolism</subject><subject>Lipid Metabolism - physiology</subject><subject>Lipids</subject><subject>Lipogenesis</subject><subject>Lipogenesis - physiology</subject><subject>Lipopolysaccharides</subject><subject>Liver</subject><subject>Liver - metabolism</subject><subject>Liver diseases</subject><subject>LPS</subject><subject>Metabolism</subject><subject>Obesity - metabolism</subject><subject>Review</subject><issn>0014-2972</issn><issn>1365-2362</issn><issn>1365-2362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kU1L3UAUhoei1Kvton9AAm7qIjrfmazKJV4_QCmUdj1MZk6uI0nmOpNY7r83Gita8GzO4jw8vIcXoW8En5BpTsH6E8IZU5_QgjApcsok3UELjAnPaVnQPbSf0h3GWBFGP6M9VsqCK0UX6OwXrMfWDD70WWiy1m-8y9IQollDZnqX-b5pTdfNhO-z4RYm6gFiVm-zarWsljfkC9ptTJvg68s-QH_OV7-ry_z658VVtbzOLVVC5ZQXlpXYNqUUwApqG-zqxoJsFBGFAMEoKOMcVbURtmTOYcfqwnBrQUjF2AH6MXs3Y92Bs9AP0bR6E31n4lYH4_X7S-9v9To8aEIkl1SpyfD9xRDD_Qhp0J1PFtrW9BDGpBnhUnHFqZjQo__QuzDGfvrvieKcKfksPJ4pG0NKEZrXNATrp3L0VI5-LmdiD9_GfyX_tTEBpzPw17ew_dikV9XVrHwEKNGYBw</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Najjar, Sonia M.</creator><creator>Shively, John E.</creator><general>Blackwell Publishing Ltd</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7763-770X</orcidid></search><sort><creationdate>202412</creationdate><title>Regulation of lipid storage and inflammation in the liver by CEACAM1</title><author>Najjar, Sonia M. ; Shively, John E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2858-247c390cf965e372cf0dbfce6f81575e532e8add28ba5c93dd0d3b7a4cce56833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adipose tissue</topic><topic>Animals</topic><topic>Antigens, CD - metabolism</topic><topic>CD36</topic><topic>CD36 antigen</topic><topic>CD36 Antigens - metabolism</topic><topic>CD66 antigen</topic><topic>CEACAM1</topic><topic>CEACAM1 protein</topic><topic>Cell Adhesion Molecules - metabolism</topic><topic>Duodenum</topic><topic>Enterocytes</topic><topic>Fatty acids</topic><topic>Fatty Acids - metabolism</topic><topic>Fatty Liver - metabolism</topic><topic>fatty liver disease</topic><topic>Hepatocytes</topic><topic>Hepatocytes - metabolism</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Inflammation - metabolism</topic><topic>Inflammatory response</topic><topic>Lipid metabolism</topic><topic>Lipid Metabolism - physiology</topic><topic>Lipids</topic><topic>Lipogenesis</topic><topic>Lipogenesis - physiology</topic><topic>Lipopolysaccharides</topic><topic>Liver</topic><topic>Liver - metabolism</topic><topic>Liver diseases</topic><topic>LPS</topic><topic>Metabolism</topic><topic>Obesity - metabolism</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Najjar, Sonia M.</creatorcontrib><creatorcontrib>Shively, John E.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Najjar, Sonia M.</au><au>Shively, John E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of lipid storage and inflammation in the liver by CEACAM1</atitle><jtitle>European journal of clinical investigation</jtitle><addtitle>Eur J Clin Invest</addtitle><date>2024-12</date><risdate>2024</risdate><volume>54</volume><issue>S2</issue><spage>e14338</spage><epage>n/a</epage><pages>e14338-n/a</pages><issn>0014-2972</issn><issn>1365-2362</issn><eissn>1365-2362</eissn><abstract>This review focuses on a special aspect of hepatic lipid storage and inflammation that occurs during nutritional excess in obesity. Mounting evidence supports that prolonged excess fatty acid (FA) uptake in the liver is strongly associated with hepatic lipid storage and inflammation and that the two processes are closely linked by a homeostatic mechanism. There is also strong evidence that bacterial lipids may enter the gut by a common mechanism with lipid absorption and that there is a set point to determine when their uptake triggers an inflammatory response in the liver. In fact, the progression from high uptake of FAs in the liver resulting in Metabolic dysfunction‐associated steatotic liver disease (MASLD) to the development of the more serious Metabolic dysfunction‐associated steatohepatitis (MASH) depends on the degree of inflammation and its progression from an acute to a chronic state. Thus, MASLD/MASH implicates both excess fatty acids and progressive inflammation in the aetiology of liver disease. We start the discussion by introduction of CD36, a major player in FA and lipopolysaccharide (LPS) uptake in the duodenum, liver and adipose tissue. We will then introduce CEACAM1, a major player in the regulation of hepatic de novo lipogenesis and the inflammatory response in the liver, and its dual association with CD36 in enterocytes and hepatocytes. We conclude that CEACAM1 and CD36 together regulate lipid droplet formation and inflammation in the liver. CEACAM1 associates with fatty acid (FA) binding protein CD36 in hepatocytes, and in the presence of LPS, forms a complex with TLR4 that phosphorylates SYK generating an inflammatory response. At the same time, phosphorylation of the ITIMs on CEACAM1 by SRC leads to recruitment of tyrosine phosphatase SHP2 that dampens the inflammation by dephosphorylation of SYK. During excess FAs and inflammation, hepatocytes begin to store triglyceride (TG) as lipid droplets (LDs) rather that export TGs in VLDL and LDL.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>39674882</pmid><doi>10.1111/eci.14338</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-7763-770X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2972
ispartof European journal of clinical investigation, 2024-12, Vol.54 (S2), p.e14338-n/a
issn 0014-2972
1365-2362
1365-2362
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11646288
source MEDLINE; Wiley Online Library All Journals
subjects Adipose tissue
Animals
Antigens, CD - metabolism
CD36
CD36 antigen
CD36 Antigens - metabolism
CD66 antigen
CEACAM1
CEACAM1 protein
Cell Adhesion Molecules - metabolism
Duodenum
Enterocytes
Fatty acids
Fatty Acids - metabolism
Fatty Liver - metabolism
fatty liver disease
Hepatocytes
Hepatocytes - metabolism
Humans
Inflammation
Inflammation - metabolism
Inflammatory response
Lipid metabolism
Lipid Metabolism - physiology
Lipids
Lipogenesis
Lipogenesis - physiology
Lipopolysaccharides
Liver
Liver - metabolism
Liver diseases
LPS
Metabolism
Obesity - metabolism
Review
title Regulation of lipid storage and inflammation in the liver by CEACAM1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A36%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20lipid%20storage%20and%20inflammation%20in%20the%20liver%20by%20CEACAM1&rft.jtitle=European%20journal%20of%20clinical%20investigation&rft.au=Najjar,%20Sonia%20M.&rft.date=2024-12&rft.volume=54&rft.issue=S2&rft.spage=e14338&rft.epage=n/a&rft.pages=e14338-n/a&rft.issn=0014-2972&rft.eissn=1365-2362&rft_id=info:doi/10.1111/eci.14338&rft_dat=%3Cproquest_pubme%3E3144438688%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3144438688&rft_id=info:pmid/39674882&rfr_iscdi=true